晶泰控股-P(02228)今日盘中大涨12.12%,引发了市场的广泛关注。相关消息显示,该公司近期取得了几项重大进展,或是导致股价上涨的原因。
首先,晶泰控股旗下Ailux Biologics与跨国制药公司优时比签署了大分子药物发现AI平台授权协议。根据协议,优时比获得使用Ailux Biologics自主开发的XtalFold™ AI平台的权利,用于大分子药物发现和设计。这表明晶泰控股在药物人工智能领域的技术实力获得了行业认可。
此外,公司在1月18日成功配售2.64亿股,募集资金11.3亿港元,规模超过其上市时的IPO募资。大规模融资为公司后续业务发展提供了充足的资金支持。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.